MedTrace Logo

Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients

NCT04450745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-04-28

No results posted yet for this study

Summary

Physical activity, along with proper nutrition, is the basis for the behavioral treatment of diabetes. In recent years exercise training in normobaric hypoxia is used in training programs for athletes and in rehabilitation. The aim of this study is the assessment of physical exercise in normobaric hypoxia condition on metabolic control of diabetes: blood glucose profile, its stability, HbA1c value, hypoglycemia: frequency, level, severity and time of occurrence, insulin demand, maximal muscle strength level, VO2max and anthropometric parameters.

Conditions

  • type1diabetes

Interventions

BEHAVIORAL

Exercise in hypoxia

60 minutes training program of mixed exercise in normobaric hypoxic chamber

BEHAVIORAL

Exercise in normoxia

60 minutes training program of mixed exercise in regular air conditions

Sponsors & Collaborators

  • The Jerzy Kukuczka Academy of Physical Education in Katowice

    collaborator OTHER

  • Silesian Centre for Heart Diseases

    lead OTHER

Principal Investigators

  • Krzysztof Strojek, Professor · Department of Internal Diseases, Diabetology and Cardiometabolic Disorders, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland

  • Marta Wróbel, PhD · Department of Internal Diseases, Diabetology and Cardiometabolic Disorders, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2020-08-31
Completion
2020-09-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04450745 on ClinicalTrials.gov